PharmaCyte Biotech (NASDAQ:PMCB) Stock Quotes, Forecast and News Summary

Q: What sector and industry does PharmaCyte Biotech (PMCB) operate in?

PharmaCyte Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

PharmaCyte Biotech Stock (NASDAQ: PMCB) stock price, news, charts, stock research, profile.

Open	$1.64
Close	$1.64
Volume / Avg.	13.85K / 33.12K
Day Range	$1.60 - $1.65
52 Wk Range	1.39 - 2.58
Market Cap	$11.15M
P/E Ratio	1.86
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	1.41%
Days to Cover	3.37

Recent News

PharmaCyte Updates Status Of Investigational New Drug Application For Pancreatic Cancer Candidate

PharmaCyte Biotech Inc (NASDAQ: PMCB)

Vandana Singh

64 Biggest Movers From Yesterday

Gainers

Lisa Levin

44 Stocks Moving In Wednesday's Mid-Day Session

Gainers AgriFORCE Growing Systems, Ltd. (NASDAQ: AGRI) shares climbed 105.3% to $4.4350. AgriFORCE Growing Systems reported binding LOI to acquire a European agriculture/horticulture and agtech consulting firm for $29 million.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$1.64
Close	$1.64
Volume / Avg.	13.85K / 33.12K
Day Range	$1.60 - $1.65
52 Wk Range	1.39 - 2.58
Market Cap	$11.15M
P/E Ratio	1.86
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	1.41%
Days to Cover	3.37

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy PharmaCyte Biotech (PMCB) stock?

You can purchase shares of PharmaCyte Biotech (NASDAQ:PMCB) through any online brokerage.

View our list of the best stock brokerages

Who are PharmaCyte Biotech (PMCB) competitors?

Other companies in PharmaCyte Biotech’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Acurx Pharmaceuticals (NASDAQ:ACXP), Imunon (NASDAQ:IMNN) and Cellectar Biosciences (NASDAQ:CLRB).

What is the forecast, or price target, for PharmaCyte Biotech (PMCB) stock?

There is no analysis for PharmaCyte Biotech to provide a consensus price target.

What is the current price for PharmaCyte Biotech (PMCB)?

The stock price for PharmaCyte Biotech (NASDAQ: PMCB) is $1.64 last updated December 20, 2024 at 4:00 PM EST.

Does PharmaCyte Biotech (PMCB) pay a dividend?

There are no upcoming dividends for PharmaCyte Biotech.

When is PharmaCyte Biotech (NASDAQ:PMCB) reporting earnings?

PharmaCyte Biotech’s Q3 earnings are confirmed for Monday, March 17, 2025.

Is PharmaCyte Biotech (PMCB) going to split?

There is no upcoming split for PharmaCyte Biotech.

What sector and industry does PharmaCyte Biotech (PMCB) operate in?

PharmaCyte Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

PharmaCyte Biotech

PharmaCyte Biotech (PMCB) Forecast